Powered by

-AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results

Mar 16, 2021 - ENP Newswire

REDWOOD CITY - AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its fourth quarter and full year 2020 financial results.

'Last year we achieved many important milestones and objectives that set the foundation for the growth of DSUVIA in 2021 and beyond, despite the global pandemic,' said Vince Angotti, Chief Executive Off...